StonvexLoading…
StonvexStonvexStonvexCore line items from HCWC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $18.25M | $78.21M | $59.50M | $40.46M |
Operating Income | $-1.62M | $-2.48M | $-1.06M | $-448.71K |
Net Income | $-3.68M | $-3.94M | $-2.28M | $-1.05M |
EPS (Diluted) | $-0.17 | $-0.24 | $-0.19 | $-0.09 |
Total Assets | $29.70M | $33.50M | $33.73M | $36.40M |
Total Liabilities | $24.96M | $26.19M | $27.82M | $30.64M |
Cash & Equivalents | $2.35M | $3.02M | $3.00M | $4.69M |
Free Cash Flow OCF − CapEx | $-271.04K | $675.42K | $1.60M | $1.95M |
Shares Outstanding | 25.37M | 19.99M | 11.99M | 11.12M |